Results
1
Undervalued Small Caps
1 companies
Zevra Therapeutics
Market Cap: US$691.8m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$12.04
7D
4.1%
1Y
27.9%
